share_log

Merit Medical Systems' (NASDAQ:MMSI) Five-year Earnings Growth Trails the 6.4% YoY Shareholder Returns

Merit Medical Systems' (NASDAQ:MMSI) Five-year Earnings Growth Trails the 6.4% YoY Shareholder Returns

Merit Medical Systems(纳斯达克股票代码:MMSI)的五年收益增长落后于6.4%的股东回报率
Simply Wall St ·  04/24 14:36

The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Merit Medical Systems, Inc. (NASDAQ:MMSI) share price is up 36% in the last five years, that's less than the market return. The last year has been disappointing, with the stock price down 4.5% in that time.

长期投资的要点是赚钱。此外,您通常希望看到股价的上涨速度快于市场。对于股东来说,不幸的是,尽管Merit Medical Systems, Inc.(纳斯达克股票代码:MMSI)的股价在过去五年中上涨了36%,但仍低于市场回报率。去年令人失望,当时股价下跌了4.5%。

Since the stock has added US$155m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

由于该股仅在过去一周的市值就增加了1.55亿美元,因此让我们看看基础表现是否推动了长期回报。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

虽然市场是一种强大的定价机制,但股价反映了投资者的情绪,而不仅仅是潜在的业务表现。通过比较每股收益(EPS)和一段时间内的股价变化,我们可以了解投资者对公司的态度是如何随着时间的推移而变化的。

During the five years of share price growth, Merit Medical Systems moved from a loss to profitability. That would generally be considered a positive, so we'd hope to see the share price to rise.

在股价增长的五年中,Merit Medical Systems从亏损转为盈利。这通常被认为是积极的,因此我们希望看到股价上涨。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

该公司的每股收益(随着时间的推移)如下图所示(点击查看确切数字)。

earnings-per-share-growth
NasdaqGS:MMSI Earnings Per Share Growth April 24th 2024
纳斯达克GS:2024年4月24日MMSI每股收益增长

We know that Merit Medical Systems has improved its bottom line over the last three years, but what does the future have in store? Take a more thorough look at Merit Medical Systems' financial health with this free report on its balance sheet.

我们知道Merit Medical Systems在过去三年中提高了利润,但是未来会发生什么?通过这份免费的资产负债表报告,更全面地了解Merit Medical Systems的财务状况。

A Different Perspective

不同的视角

Merit Medical Systems shareholders are down 4.5% for the year, but the market itself is up 27%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 6% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Merit Medical Systems better, we need to consider many other factors. For example, we've discovered 1 warning sign for Merit Medical Systems that you should be aware of before investing here.

Merit Medical Systems的股东今年下跌了4.5%,但市场本身上涨了27%。即使是优质股票的股价有时也会下跌,但我们希望在过于感兴趣之前看到企业基本指标的改善。好的一面是,长期股东赚了钱,在过去的五年中,每年增长6%。最近的抛售可能是一个机会,因此可能值得查看基本面数据以寻找长期增长趋势的迹象。长期跟踪股价表现总是很有意思的。但是,为了更好地了解Merit Medical Systems,我们需要考虑许多其他因素。例如,我们发现了Merit Medical Systems的1个警告信号,在投资这里之前,你应该注意这个信号。

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一样,那么你不会想错过这份业内人士正在收购的成长型公司的免费名单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发